Marker Therapeutics, Inc. · NASDAQ:MRKR
Blue Owl Capital Holdings LP reported a 9.99% stake in Marker Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 15, 2025
Blue Owl Capital Holdings LP reported a 9.99% stake in Marker Therapeutics, Inc., 1,127,052 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 1,127,052
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Blue Owl Capital Holdings LP | 9.99% | 1,127,052 |
Source
Related
- Marker Therapeutics, Inc.
- Blue Owl Capital Holdings LP
- Marker Therapeutics, Inc. shareholders
- Schedule 13G · Blue Owl Capital Holdings LP · Feb 14, 2025
- Schedule 13D/A · New Enterprise Associates 16, L.P. · Nov 17, 2025
- Schedule 13G/A · Alyeska Investment Group, L.P. · Nov 14, 2025
- Schedule 13D/A · New Enterprise Associates 16, L.P. · Aug 18, 2025
- Schedule 13G · Alyeska Investment Group, L.P. · Feb 14, 2025
- Schedule 13D/A · New Enterprise Associates 16, L.P. · Dec 23, 2024